Quickly Spot Consensus Among the World’s Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
109%
upside
5 price targets
|
0
%
|
|
|
|
109%
upside
8 price targets
|
0
%
|
|
|
|
107%
upside
6 price targets
|
0
%
|
|
|
|
NBIS
104
Nebius Group N.V.
NBIS
$19.7B
|
107%
upside
5 price targets
|
0
%
|
|
|
107%
upside
8 price targets
|
0
%
|
|
|
|
107%
upside
10 price targets
|
0
%
|
|
|
|
106%
upside
5 price targets
|
0
%
|
|
|
|
105%
upside
3 price targets
|
0
%
|
|
|
|
105%
upside
4 price targets
|
0
%
|
|
|
|
102%
upside
3 price targets
|
0
%
|
|
|
111
Taysha Gene Therapies
TSHA
$1.49B
|
102%
upside
5 price targets
|
0
%
|
|
|
101%
upside
12 price targets
|
0
%
|
|
|
|
101%
upside
4 price targets
|
0
%
|
|
|
|
98%
upside
7 price targets
|
0
%
|
|
|
|
96%
upside
5 price targets
|
0
%
|
|
|
|
96%
upside
6 price targets
|
0
%
|
|
|
|
96%
upside
4 price targets
|
0
%
|
|
|
|
95%
upside
3 price targets
|
0
%
|
|
|
|
94%
upside
4 price targets
|
0
%
|
|
|
|
94%
upside
3 price targets
|
0
%
|
|
|
|
94%
upside
4 price targets
|
0
%
|
|
|
|
92%
upside
3 price targets
|
0
%
|
|
|
|
90%
upside
18 price targets
|
0
%
|
|
|
|
89%
upside
3 price targets
|
0
%
|
|
|
|
89%
upside
5 price targets
|
0
%
|
|